Robbert Q Kim

14PUBLICATIONS
66CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Wastewater treatment processesMajor global burdens of diseasePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 19, 2026
USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production.

|Apr 06, 2026
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma.

Ziyun Cheng, Mohamadreza Amin, Mandy van Brakel

|Feb 04, 2026
Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxA.

Arina Koroleva, Erika Artukka, Keith Yamada

|Sep 17, 2024
Covalent Probes To Capture Legionella pneumophila Dup Effector Enzymes.

Max S Kloet, Rishov Mukhopadhyay, Rukmini Mukherjee

|May 07, 2024
Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell.

Yuqing Jia, Merve Oyken, Robbert Q Kim

|Aug 29, 2023
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2.

Jin Gan, Jelle de Vries, Jimmy J L L Akkermans

Pageof 3

Frequent Collaborators

5 joint publications

Aysegul Sapmaz

5 joint publications

Paul P Geurink

4 joint publications

Peter A van Veelen

4 joint publications

Huib Ovaa